Atlas Trials

Safety Study of Oral Edaravone Administered in Subjects With ALS

Clinical trial NCT04165824 · COMPLETED

Trial details

NCT number
NCT04165824
Sponsor
Shionogi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
ALS
Start date
2019-11-18
Primary completion
2021-10-07
Enrollment
185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.